CRS plus HIPEC in stage IIIc epithelial ovarian cancer and comparison of oncological outcome only with CRS and IV chemotherapy and CRS plus IP chemotherapy.-MedSci.cn

CRS plus HIPEC in stage IIIc epithelial ovarian cancer and comparison of oncological outcome only with CRS and IV chemotherapy and CRS plus IP chemotherapy.

Somashekhar, SP; Kumar, CR; Rajgopal, AK; Yethadka, R; Zaveri, S; Ahuja, V; Rauthan, A; Patil, P

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

科室
- - 订阅+
  - 更多科室
工具
服务